Menu +

Tag: study

BioNTech and Pfizer Announce Nature Publication of German Phase 1/2 Study Data from mRNA-based Vaccine Candidate BNT162b1 Against SARS-CoV-2

BioNTech SE (Nasdaq: BNTX) and Pfizer Inc. (NYSE: PFE) today announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2 Study of BNT162b1 were published online in the journal Nature. BNT162b1 is part of the companies’ mRNA-based vaccine development program Lightspeed against SARS-CoV-2. The preliminary clinical data from the German study of BNT162b1, a […]

Roche’s Tecentriq in combination with chemotherapy (including Abraxane) meets primary endpoint of improved pathological complete response

…. regardless of PD-L1 status, as initial treatment for people with early triple-negative breast cancer • IMpassion031 data will be discussed with health authorities globally, including the US Food and Drug Administration and the European Medicines Agency • Tecentriq is the only approved cancer immunotherapy for the treatment of metastatic triple-negative breast cancer, a very […]

RECOVER – the Paul-Ehrlich-Institut Authorises another COVID-19 Therapy Study with Reconvalescent Plasma

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines has authorised the second clinical study with COVID-19 reconvalescent plasma (RECOVER) in Germany. The purpose of such clinical trials is to gain insights into the safety and efficacy of COVID-19 reconvalescent plasma in the treatment of serious COVID-19 infections. Patients to be treated include old and high-risk […]

Paul-Ehrlich-Institut Approves First COVID-19 Therapy Study with Convalescent Plasma

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has granted approval for the first clinical trial with COVID-19 convalescent plasma (CAPSID) in Germany. The aim of the clinical trial is to gain insights into the efficacy and safety of COVID-19 convalescent plasma in the treatment of severe COVID-19 diseases. The ethics committee has also issued […]